Home › Funds › Townsend & Associates, Inc › EW
Townsend & Associates, Inc position in EW
EDWARDS LIFESCIENCES CORP · Health Care
Townsend & Associates, Inc reported holding 206,533 shares of EW (EDWARDS LIFESCIENCES CORP) in its Q3 2026 13F filing — a position valued at US$17.9M, representing 1.51% of its reported portfolio and ranking #29 among its reported holdings. Townsend & Associates, Inc has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR
How Townsend & Associates, Inc's EW position evolved
Townsend & Associates, Inc first disclosed a stake in EW in Q3 2023 at 76,404 shares (US$4.7M). The position peaked in Q3 2026 at 206,533 shares, worth US$17.9M. Across 13 filings, Townsend & Associates, Inc increased the stake 11 time(s), trimmed it 1 time(s) and left it unchanged 0 time(s). The most recent filing (Q3 2026) shows 206,533 shares valued at US$17.9M — an increase of 3,132 shares quarter over quarter.. Notable position changes include a 110% increase in Q4 2023 (shares rose 25% over the following quarter).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2023 | 76.40K | $4.71M | New |
| Q4 2023 | 160.71K | $11.66M | Add |
| Q1 2024 | 162.58K | $14.27M | Add |
| Q2 2024 | 166.54K | $10.39M | Add |
| Q3 2024 | 174.98K | $12.36M | Add |
| Q4 2024 | 180.75K | $12.65M | Add |
| Q1 2025 | 214.80K | $14.86M | Add |
| Q2 2025 | 184.18K | $14.73M | Reduce |
| Q3 2025 | 190.33K | $14.21M | Add |
| Q4 2025 | 193.66K | $16.36M | Add |
| Q1 2026 | 199.47K | $16.26M | Add |
| Q2 2026 | 203.40K | $17.29M | Add |
| Q3 2026 | 206.53K | $17.89M | Add |
Dots on the line are colored by change type; missing quarters mean no position was reported.
About EW and 13F data
EW (EDWARDS LIFESCIENCES CORP) is a Health Care company. 31 other funds we track also report a position in EW — the largest reported positions include Belvedere Trading LLC (US$25.63B), DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt (US$1.18B), Ninety One UK Ltd (US$1.03B). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding EW
- Belvedere Trading LLC 3.30M sh · $25.63B · Q3 2026
- DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt 13.00M sh · $1.18B · Q2 2026
- Ninety One UK Ltd 11.94M sh · $1.03B · Q3 2026
- Aristotle Capital Management, LLC 8.67M sh · $783.91M · Q2 2026
- BROWN ADVISORY INC 7.37M sh · $666.33M · Q2 2026
- Artisan Partners Limited Partnership 6.09M sh · $525.69M · Q3 2026
More on Townsend & Associates, Inc
FAQ
How long has Townsend & Associates, Inc held EW?
Townsend & Associates, Inc has disclosed EW holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Townsend & Associates, Inc's current position in EW?
As of Q3 2026, Townsend & Associates, Inc holds 206.53K shares of EW (EDWARDS LIFESCIENCES CORP), valued at $17.89M, representing 1.51% of its reported portfolio and ranking #29.
Has Townsend & Associates, Inc been buying or selling EW?
In the latest 13F filing (Q3 2026), Townsend & Associates, Inc increased its position in EW. The position peaked in Q3 2026 at 206.53K shares.
Which other funds hold EW?
Other major institutional holders of EW include Belvedere Trading LLC, DZ BANK AG Deutsche Zentral Genossenschafts Bank, Frankfurt, Ninety One UK Ltd, among 31 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.